Supreme Court Ruling Bolsters Licensee Rights
The ruling came amid wrangling between business and government over whether patents are too easily approved, preventing rather than inspiring inventions.
The biotech rivals have been battling over a Genentech patent covering Synagis, one of MedImmune’s blockbuster drugs, which brings in more than $1 billion in sales each year.
Already a subscriber? Click here to login